相关实验视频

Updated: Mar 6, 2026

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

升高的脂蛋白 (a) 和晚期冠状动脉化不良结果:血管内超声波研究

Shaowu Xiao^1,2, Mengya Zeng¹, Junru He^1,2

¹Department of Cardiovascular Internal Medicine, The Second Affiliated Hospital of Hainan Medical University, Haikou, 570103, China.

International journal of cardiology. Cardiovascular risk and prevention

|March 5, 2026

概括

冠状动脉化 (CAC) 患者的升高脂蛋白[Lp(a) ]表明具有高风险的表型. 这种表型与更糟糕的心血管结果有关,包括主要不良心血管事件 (MACE),缺血性中风和静脉支架静止症.

科学领域:

心脏病学心脏病学
动脉样硬化研究动脉样硬化研究
脂质代谢脂质代谢是什么

背景情况:

冠状动脉化 (CAC) 是晚期动脉样硬化和心血管风险增加的标志物.
脂蛋白 (Lp) 是已知的动脉样硬化病的因果风险因素,但其在晚期CAC中的作用尚未完全理解.

研究的目的:

调查Lp (a) 水平升高与体内病变形态之间的关联.
确定高Lp (a) 和症状性,晚期CAC患者的临床结果之间的关系.

主要方法:

对292名血管内超声波 (IVUS) 确诊的CAC.患者进行了回顾性队列研究.
患者分为升高 (≥50 mg/dL) 和低 (<50 mg/dL) Lp.a) 群体.
主要不良心血管事件 (MACE) 作为主要终点,使用多变量Cox模型进行分析.

主要成果:

升高的Lp (a) 组显示大动脉膜化增加和狭窄的血管重塑.
在升高的Lp(a) 组中,MACE率显著更高 (37.7%对比15.8%).
升高的Lp (a) 独立地预测了缺血性中风和静脉静脉复缩的风险增加.

结论:

升高的Lp (a) 标识了严重CAC的症状患者的高风险表型.
这种表型的特点是收缩性重塑和明显增加的MACE风险,特别是缺血性中风和静脉支架缩.
建议在严重的CAC患者中进行常规Lp (a) 测试,以确定风险分层,以指导加强监测和治疗.

关键词:

严格的改造严格的改造冠状动脉结石化导致冠状动脉结石化血管内超声波血管内超声波脂蛋白 (a) 是一种蛋白质主要的不良心血管事件.

更多相关视频

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Imaging and Analysis of Oil Red O-Stained Whole Aorta Lesions in an Aneurysm Hyperlipidemia Mouse Model

Imaging and Analysis of Oil Red O-Stained Whole Aorta Lesions in an Aneurysm Hyperlipidemia Mouse Model

Published on: May 2, 2022

相关概念视频

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Peripheral Artery Disease I: Introduction

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...